Evidence map›Paper›PMID 42431859›Full record

ArticleNature communications2026

Spin-controlled enantioselective near-infrared photocatalysis with chiral MgO/Co

Hui Zhangsun, Rui Hu, Liguang Xu, Chuanlai Xu, Hua Kuang, Changlong Hao

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Mn Doping-Induced Charge-Carrier Redistribution in CoMolecules (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hui ZhangsunInternational Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, China.
Rui HuInternational Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, China.
Liguang XuInternational Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, China. xlg@jiangnan.edu.cn.ORCID http://orcid.org/0000-0001-9453-7703
Chuanlai XuInternational Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, China.ORCID http://orcid.org/0000-0002-5639-7102
Hua KuangInternational Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, China. kuangh@jiangnan.edu.cn.ORCID http://orcid.org/0000-0002-2724-8722
Changlong HaoInternational Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, China. changlongup@163.com.ORCID http://orcid.org/0000-0003-1784-0420

Funding

National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund) 32471430
6 · The paper itself

Abstract

Herein, we report D-/L-penicillamine-mediated magnesium oxide-doped cobalt oxide nanoparticles that exhibit strong mirror-image circular dichroism signals ( ~ 102 mdeg at ~800 nm) and function as effective near-infrared-driven photocatalysts for the enantioselective hydroxylation of tyrosine to dihydroxyphenylalanine. The D-nanoparticles demonstrated pronounced enantioselectivity, consuming 92.48% of L-tyrosine versus only 53.85% of D-tyrosine. Magnesium incorporation proves essential, increasing catalytic activity by 22.78 percentage points relative to undoped cobalt oxide nanoparticles. Mechanistically, Mg incorporation modulates the electronic structure to induce surface oxygen vacancies, which act as electron bridges to facilitate oxygen activation, significantly lowering the reaction barrier. Molecular dynamics simulations further unveil an inverse affinity-activity relationship, where heterochiral pairs enable efficient catalytic turnover through weaker, transient single hydrogen bonds, whereas high-affinity homochiral pairs are sequestered in non-productive states via rigid dual hydrogen bonds. This work establishes a distinct paradigm for rational catalyst design, balancing binding affinity with catalytic mobility.

Identifiers

PMID42431859
PMCPMC13354766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.